JPWO2024242150A1 - - Google Patents
Info
- Publication number
- JPWO2024242150A1 JPWO2024242150A1 JP2025522440A JP2025522440A JPWO2024242150A1 JP WO2024242150 A1 JPWO2024242150 A1 JP WO2024242150A1 JP 2025522440 A JP2025522440 A JP 2025522440A JP 2025522440 A JP2025522440 A JP 2025522440A JP WO2024242150 A1 JPWO2024242150 A1 JP WO2024242150A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14151—Methods of production or purification of viral material
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023084423 | 2023-05-23 | ||
| JP2024007357 | 2024-01-22 | ||
| JP2024007358 | 2024-01-22 | ||
| JP2024063328 | 2024-04-10 | ||
| PCT/JP2024/018896 WO2024242150A1 (ja) | 2023-05-23 | 2024-05-22 | 改変された組換えアデノ随伴ウイルス（ａａｖ）結合性タンパク質およびａａｖの精製方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2024242150A1 true JPWO2024242150A1 (https=) | 2024-11-28 |
| JPWO2024242150A5 JPWO2024242150A5 (https=) | 2026-02-10 |
Family
ID=93589449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025522440A Pending JPWO2024242150A1 (https=) | 2023-05-23 | 2024-05-22 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP4717706A1 (https=) |
| JP (1) | JPWO2024242150A1 (https=) |
| CN (1) | CN121358762A (https=) |
| WO (1) | WO2024242150A1 (https=) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021106882A1 (ja) * | 2019-11-25 | 2021-06-03 | 東ソー株式会社 | 改良アデノ随伴ウイルス結合性タンパク質、当該タンパク質の製造方法および当該タンパク質を用いたアデノ随伴ウイルス吸着剤 |
| JP2021526829A (ja) * | 2018-06-14 | 2021-10-11 | リジェネクスバイオ インコーポレイテッド | 組換えａａｖ生成のためのアニオン交換クロマトグラフィー |
| JP2022138144A (ja) * | 2021-03-09 | 2022-09-22 | Ｊｃｒファーマ株式会社 | 組換えａａｖ９ビリオンの製造方法 |
| WO2023023541A1 (en) * | 2021-08-17 | 2023-02-23 | Ultragenyx Pharmaceutical Inc. | Anion-exchange chromatography methods for purification of recombinant adeno-associated viruses |
| WO2023140197A1 (ja) * | 2022-01-21 | 2023-07-27 | 東ソー株式会社 | 改変された組換えアデノ随伴ウイルス（ａａｖ）結合性タンパク質及び感染能に基づくａａｖの分析方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011097898A (ja) | 2009-11-09 | 2011-05-19 | Sagami Chemical Research Institute | 組換えＦｃ受容体およびそれの製造方法 |
-
2024
- 2024-05-22 WO PCT/JP2024/018896 patent/WO2024242150A1/ja not_active Ceased
- 2024-05-22 CN CN202480033591.4A patent/CN121358762A/zh active Pending
- 2024-05-22 JP JP2025522440A patent/JPWO2024242150A1/ja active Pending
- 2024-05-22 EP EP24811156.9A patent/EP4717706A1/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021526829A (ja) * | 2018-06-14 | 2021-10-11 | リジェネクスバイオ インコーポレイテッド | 組換えａａｖ生成のためのアニオン交換クロマトグラフィー |
| WO2021106882A1 (ja) * | 2019-11-25 | 2021-06-03 | 東ソー株式会社 | 改良アデノ随伴ウイルス結合性タンパク質、当該タンパク質の製造方法および当該タンパク質を用いたアデノ随伴ウイルス吸着剤 |
| JP2022138144A (ja) * | 2021-03-09 | 2022-09-22 | Ｊｃｒファーマ株式会社 | 組換えａａｖ９ビリオンの製造方法 |
| WO2023023541A1 (en) * | 2021-08-17 | 2023-02-23 | Ultragenyx Pharmaceutical Inc. | Anion-exchange chromatography methods for purification of recombinant adeno-associated viruses |
| WO2023140197A1 (ja) * | 2022-01-21 | 2023-07-27 | 東ソー株式会社 | 改変された組換えアデノ随伴ウイルス（ａａｖ）結合性タンパク質及び感染能に基づくａａｖの分析方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4717706A1 (en) | 2026-04-01 |
| CN121358762A (zh) | 2026-01-16 |
| WO2024242150A1 (ja) | 2024-11-28 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251113 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260122 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20260122 |
|
| A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20260122 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260303 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260316 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20260324 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20260406 |